The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.
Clinical trial NCT03577704 · COMPLETED
Trial details
- NCT number
- NCT03577704
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2022-09-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.